Day One: Friday 23 April 2021

All times are in GMT+1

SessionTimeSpeaker
Welcome to IKCS:Europe 202110:00Samra Turajlic, MD, PhD
Surgical Session Panel Discussion10:05Chairs:
Lars Lund, MD, PhD and Michael Staehler, MD
Panelists:
Karim Bensalah, MD, PhD
Tim O’Brien, MD
Saeed Dabestani, MD, PhD
Arnaud MeJean, MD, PhD
Maxine Tran, MBBS, PhD, FRCS(UROL)
Alessandro Volpe, MD, PhD
Break11:35
Systemic Therapy Session12:00Chairs:
Thomas Powles, MD, MBBS, MRCP
Manuela Schmidinger, MD
Treating with VEGF + IO or Ipi/Nivo: Which
Approach?
Brian Rini, MD, FASCO
Modern Therapeutic Approaches in Second-Line and
Later Therapies
Camillo Porta, MD
Discussion and Q+ABrian Rini, MD, FASCO
Camillo Porta, MD
Tissue-Based Biomarkers for Potential Clinical Adoption in Renal CancerThomas Powles, MD, MBBS, MRCP
Circulating Biomarkers for Potential Clinical Adoption
in Renal Cancer
Toni K. Choueiri, MD
Discussion and Q+AThomas Powles, MD, MBBS, MRCP
Toni K. Choueiri, MD
Non-Clear Cell Panel Discussion Chairs: Lars Lund, MD, PhD and Gabriel Malouf, MD, PhD
Panelists:
Laurence Albiges, MD, PhD
Mark Ball, MD
Axel Bex, MD, PhD
Holger Moch, MD
Manuela Schmidinger, MD
Nizar M. Tannir, MD, FACP
Break13:30
Keynote Lecture
Kidney Cancer as a Model for a Curable Neoplasm
14:15David F. McDermott, MD
Day One Adjournment15:00
Poster Walk/Networking15:00 to
16:00
Gabriel Malouf, MD, PhD
Guillermo de Velasco, MD, PhD

Day Two: Saturday 24 April 2021

All times in GMT+1

SessionTimeSpeaker
Welcome10:00Samra Turajlic, MD, PhD
Christopher G. Wood, MD, FACS
New Directions/Management of Systemic Therapies10:05Moderators:
Lars Lund, MD, PhD
Samra Turajlic, MD, PhD
Future Therapeutic Approaches in RCC Hans Hammers, MD, PhD
Designing Biomarker-Driven Trials: Opportunities
and Challenges
Yann Vano, MD, PhD
Impact and Manipulation of MicrobiomesLisa DeRosa, MD
Discussion and Q+A
Break11:05
Basic Science Session11:30Chairs: Bernard J. Escudier, MD
John B. Haanen, MD, PhD
Role of the Tumor Microenvironment in Renal CancerBarbara Seliger, MD, PhD
Targeting the Tumor Microenvironment in Renal Cancer:
The Role of T and B Cells
Catherine Fridman, MD
What Is the Source of Immune Infiltration in RCC?Samra Turajlic, MD, PhD
WoodFire Round Tables12:30Moderator:
Christopher G. Wood, MD, FACS
Panelists:
Laurence Albiges, MD, PhD
Christian Beisland, MD, PhD
Hans Hammers, MD, PhD
Lars Lund, MD, PhD
Sylvie Negrier, MD, PhD
Lisa Pickering, MBBS, MA, FRCP, PhD
Tom Waddell, MD, MBChB, MRCP
Closing Remarks and Adjournment14:00Frede Donskov, MD, DMSc
Adjournment14:05